The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
MicroRNAs 103 and 107 regulate insulin sensitivity
Open accessAbstract
Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes. MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism. However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MicroRNA inhibitors (antagomirs) targeting miR-103 and miR-107 improve insulin sensitivity and reduce adiposity in diet-induced obese mice by enhancing hepatic and peripheral insulin signaling [92].”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citationCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,259
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,456
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E. R., Hanson, E. M., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,023
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591
Xie, H., Lim, B., & Lodish, H. F. (2009) · Diabetes · doi:10.2337/db08-1299 · Cited by 586
MiRNA Expression Profile of Human Subcutaneous Adipose and during Adipocyte Differentiation
Ortega, F. J., Moreno‐Navarrete, J. M., Pardo, G., Sabater, M., Hummel, M., Ferrer, A., Rodríguez‐Hermosa, J. I., Ruiz, B., Ricart, W., Peral, B., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009022 · Cited by 417
MicroRNAs: A new class of regulatory genes affecting metabolism
Krützfeldt, J., & Stoffel, M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.009 · Cited by 416
Self-citationMolecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. T. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 395
Cohen, A. W., Razani, B., Wang, X., Combs, T. P., Williams, T. M., Scherer, P. E., & Lisanti, M. P. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00006.2003 · Cited by 362
Caveolin Is an Activator of Insulin Receptor Signaling
Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M. P., Myers, M. G., & Ishikawa, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26962 · Cited by 302
Herrera, B. M., Lockstone, H. E., Taylor, J. M., Ria, M., Barrett, A., Collins, S. C., Kaisaki, P. J., Argoud, K., Fernández, C., Travers, M. E., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1667-2 · Cited by 294
MicroRNA let-7 regulates 3T3-L1 adipogenesis.
Sun, T.-W., Fu, M., Bookout, A., Kliewer, S., & Mangelsdorf, D. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0298 · Cited by 277
MicroRNA and 3T3-L1 pre-adipocyte differentiation
Kajimoto, K., Naraba, H., & Iwai, N. (2006) · RNA · doi:10.1261/rna.7228806 · Cited by 240
Role of caveolin and caveolae in insulin signaling and diabetes
Cohen, A. W., Combs, T. P., Scherer, P. E., & Lisanti, M. P. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00324.2003 · Cited by 222
Nyström, F. H., Chen, H., Cong, L.-N., Li, Y., & Quon, M. J. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.12.0392 · Cited by 203
Minehira, K., Young, S. G., Villanueva, C. J., Yetukuri, L., Orešič, M., Hellerstein, M. K., Farese, R. V., Horton, J. D., Preitner, F., Thorens, B., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800248-jlr200 · Cited by 174
Characterization of the Inhibitory Effect of Growth Hormone on Primary Preadipocyte Differentiation
Hansen, L., Madsen, B., Teisner, B., Nielsen, J. H., & Billestrup, N. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.8.0154 · Cited by 118
Preitner, F., Mody, N., Graham, T. E., Peroni, O. D., & Kahn, B. B. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2009 · Cited by 106
Tozzo, E., Shepherd, P. R., Gnudi, L., & Kahn, B. B. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.5.e956 · Cited by 82
Knockout Mice Challenge our Concepts of Glucose Homeostasis and the Pathogenesis of Diabetes
Kahn, C. R. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.169 · Cited by 56
Caveolin gene transfer improves glucose metabolism in diabetic mice
Otsu, K., Toya, Y., Oshikawa, J., Kurotani, R., Yazawa, T., Sato, M., Yokoyama, U., Umemura, S., Minamisawa, S., Okumura, S., et al. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00077.2009 · Cited by 29
Flagged first, then by citations
Cited by
Sorted by citations
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,872
Adipose-derived circulating miRNAs regulate gene expression in other tissues
Thomou, T., Mori, M. A., Dreyfuss, J. M., Konishi, M., Sakaguchi, M., Wolfrum, C., Rao, T. N., Winnay, J. N., Garcia-Martin, R., Grinspoon, S. K., et al. (2017) · Nature · doi:10.1038/nature21365 · Cited by 1,539
Hammond, S. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.001 · Cited by 1,324
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
Metadata
- Authors
- Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- University of Basel (CH)
- Regulus Therapeutics (United States) (US)
- University Hospital of Basel (CH)
- Corresponding author
- Stoffel, Markus
- Venue
- Nature
- Published
- 2011-06
- Volume
- 474
- Issue
- 7353
- Pages
- 649-653
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075317528
- Cited by
- 1,000
- References
- 27
- Citations by year
- 2026: 36 · 2025: 34 · 2024: 54 · 2023: 45 · 2022: 61 · 2021: 61 · 2020: 71 · 2019: 68 · 2018: 80 · 2017: 65 · 2016: 98 · 2015: 90 · 2014: 90 · 2013: 77 · 2012: 57
- FWCI
- 25.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- Juvenile Diabetes Research Foundation International
- Fondation Leducq
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- microRNA-107, insulin sensitivity, caveolin-1, insulin signaling, insulin receptor, glucose homeostasis, obesity, type 2 diabetes, adipocytes, liver, insulin-stimulated glucose uptake, adipocyte size, miRNA target genes
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Glucose, Homeostasis, Hyperglycemia, Insulin, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Up-Regulation, Gene Expression, Adipocytes, Gene Silencing, MicroRNAs, Cell Size, Caveolin 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
